Clinical efficacy and cost of Allogenic Acellular Dermal Matrix (AADM) in implant-based breast reconstruction of post mastectomy cancer patients
Efsandiari S, Dendukuri N, McGregor M
Record ID 32010000173
English
Authors' recommendations:
There is no evidence that use of AADM increases the risk of perioperative complications.Its use is reported to be associated with fewer breast revision procedures, but convincing evidence for this is not yet available in peer reviewed literature.It is the conviction of a member of our staff who has studied the procedure that use of AADM for breast reconstruction surgery at the MUHC would shorten the surgical procedure and result in superior aesthetic outcomes. He estimates that this would also permit 9 (i.e. 15%) of the projected 60 women (11 procedures) undergoing breast reconstruction each year to avoid breast revision surgery. To the extent that these projections prove to be correct the net incremental cost of each breast reconstruction using AADM could be reduced.
Details
Project Status:
Completed
URL for project:
http://www.mcgill.ca/files/tau/DERMAMATRIX_FINAL_JUNE_09.pdf
Year Published:
2009
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Biocompatible Materials
- Breast Neoplasms
- Collagen
- Mammaplasty
- Mastectomy
- Skin, Artificial
- Tissue Expansion Devices
Contact
Organisation Name:
Technology Assessment Unit of the McGill University Health Centre (MUHC)
Contact Address:
Technology Assessment Unit of the MUHC, 536-5100 Boul. Maisonneuve O, Montreal, H4A 3T2
Contact Name:
eva.suarthana@mcgill.ca
Contact Email:
nisha.almeida@muhc.mcgill.ca
Copyright:
Technology Assessment Unit of the McGill University Health Centre (MUHC)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.